(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

INJECTAFER

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

INJECTAFER

ST13

US500000087023433

Class

16, 44

Filing

87023433

Registration

5154434

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

21

Latest update

03/08/2026

Trademark type

Combined

Nice classes

16, 44

Filing date

05/03/2016

Registration date

03/07/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/08/2023

Last transaction

03/08/2026

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

First use anywhere

07/26/2013

First use in commerce

07/26/2013

Drawing code

3

Owner type

03

Owner location

St. Gallen, CH

Examiner

PARKER, JUSTINE D

Law office

L10

Current location

TMEG LAW OFFICE 101

Mark description

The mark consists of the word "injectafer" in stylized letters with a circle filled with smaller circles to the left all on a rectangular background.

Holders and representatives

Holders

Vifor (International) AG (Vifor (International) Ltd.) (Vifor (International) Inc.)

Representatives

Julianne Abelman Womble Bond Dickinson (US) LLP

Technical classification

Nice Classes

Class 16Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 16

Booksbooklets and brochures featuring health and medical information in the field of iron deficiency; booksbooklets and brochures featuring information regarding the treatment of iron deficiency; booksbooklets and brochures featuring pharmaceutical data and pharmaceutical counseling information and medical and pharmaceutical advice in the field of iron deficiency

Class 44

Providing an online computer database featuring health and medical information in the field of iron deficiency; providing an online computer database featuring information regarding the treatment of iron deficiency; providing an online computer database featuring pharmaceutical data relating to the diagnosticprophylactic and therapeutic properties of pharmaceuticals and pharmaceutical counseling information; providing online computer database featuring medical and pharmaceutical advice in the field of iron deficiency

Publications

History of USPTO decisions and trademark events.

21 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

03/07/2026

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/08/2023

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/08/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/08/2023

E815

TEAS SECTION 8 & 15 RECEIVED

02/09/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

03/07/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

03/07/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/20/2016

PUBO

PUBLISHED FOR OPPOSITION

12/20/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/30/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/09/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/31/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/31/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/31/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/25/2016

GNRT

NON-FINAL ACTION E-MAILED

08/25/2016

CNRT

NON-FINAL ACTION WRITTEN

08/25/2016

DOCK

ASSIGNED TO EXAMINER

08/18/2016

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

05/10/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/07/2016

NWAP

NEW APPLICATION ENTERED

05/06/2016

Continuous trademark protection

Get notified about every new filing that threatens INJECTAFER or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.